A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

Patients in the study had tumors with a genetic defect known as deficient DNA mismatch repair, or dMMR. About 15% of colon ...

The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...

The drug is being hailed as a miracle cure, but new research now reveals yet another serious side effect. The post Experts ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

An Israeli study has found that patients taking the weekly jab - or similar drugs - were twice as likely to suffer from a ...

A Weight Loss Illusion with Dangers Ahead** In an age where the quest for quick fixes dominates our society, the emergence of Ozempic as the ...